High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity
- 30 September 1991
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 9 (9), 631-637
- https://doi.org/10.1016/0264-410x(91)90187-b
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Protective Effects of Towne Cytomegalovirus Vaccine Against Low-Passage Cytomegalovirus Administered as a ChallengeThe Journal of Infectious Diseases, 1989
- Monoclonal Antibodies Directed to Two Groups of Viral Proteins Neutralize Human Cytomegalovirus In VitroHybridoma, 1987
- Resistance of Seropositive Volunteers to Subcutaneous Challenge with Low-Passage Human CytomegalovirusThe Journal of Infectious Diseases, 1985
- Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirusVirology, 1984
- TOWNE-VACCINE-INDUCED PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER RENAL TRANSPLANTSThe Lancet, 1984
- Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteinsVirology, 1984
- Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' ExperienceClinical Infectious Diseases, 1982
- Cytomegalovirus Infections Following Renal TransplantationClinical Infectious Diseases, 1981
- Clinical Trials of Immunization with the Towne 125 Strain of Human CytomegalovirusThe Journal of Infectious Diseases, 1976
- The Cytomegaloviruses: Ubiquitous Agents with Protean Clinical ManifestationsThe New England Journal of Medicine, 1971